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Dear Sir,
With interest we read the study by Cho et al [1], evaluating
the usefulness of FDG PET/CT for differentiating malig-
nant endobronchial lesions with distal atelectasis from
benign bronchial stenosis. In this retrospective study, they
adequately demonstrated the additional value of FDG PET/
CT in this challenging clinical problem. Besides differen-
tiation of endobronchial lesions, accurate discrimination
between malignant tumours and atelectatic lung tissue can
facilitate the definition of radiotherapy target volumes. As a
result, the size of radiotherapy fields can be decreased [2],
potentially reducing radiotherapy-induced side-effects.
For these purposes, the PET technique may be of
additional value to discriminate the obstructive lesion from
the atelectatic lung tissue. Although Cho et al [1]
mentioned different patterns of FDG uptake in atelectatic
lung tissue, we wonder whether the FDG uptake in the
obstructive lesions could be adequately distinguished from
the FDG uptake in the atelectatic lung tissue. As FDG
uptake is dependent on perfusion for its delivery to tissue,
variation in tissue vascularity may contribute to variable
FDG uptake in obstructive atelectasis. In a previous PET/
CT study, we quantified tumour perfusion in lung cancer
patients using radiolabelled water ([15O]H2O) [3]. The
measured perfusion values in atelectatic lung tissue differed
significantly as compared with perfusion values in malig-
nant tumours. Figure 1 shows an example of a patient with
relatively high perfusion in atelectatic lung tissue as
compared with the malignant tumour. These observations
suggest that perfusion measurements may have additional
value to discriminate atelectatic lung tissue from malignant
lesions. Therefore, we believe that additional perfusion
measurements of atelectatic lung tissue may improve
diagnosis and radiotherapy planning of malignant endo-
bronchial lesions.
A reply to this letter can be found at doi:10.1007/s00330-011-2170-y.
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Fig. 1 PET-CT images of obstructive atelectasis in a 52-year old male
patient with metastatic non-small cell lung cancer. The parametric
perfusion image in Fig. 1a demonstrates high perfusion (arrow) in
obstruction atelectasis, whereas the perfusion in the primary tumour
(*) is substantially lower. Figs. 1b and c represent corresponding low-
dose CT and fused PET-CT images, respectively
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